Glucan Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Form, Process, End User, Functionality

Description

The global Glucan Market is projected to grow from $0.7 billion in 2025 to $1.4 billion by 2035, at a compound annual growth rate (CAGR) of 7.5%. The glucan market is supported by expanding scientific validation and regulatory recognition of B-glucan ingredients for food and nutraceutical applications. In 2025, the European Food Safety Authority published an updated scientific opinion confirming the health claim for oat and barley B-glucans in reducing postprandial glycaemic responses, reinforcing their use in functional food formulations across Europe. This regulatory validation is expected to support wider commercialization of B-glucan ingredients in dietary supplements, functional foods, beverages, and clinical nutrition products.

The Type segment of the Glucan Market includes beta-glucan, alpha-glucan, and others. Beta-glucan represents the dominant market segment due to its scientifically validated health benefits, including immune system support, cholesterol reduction, blood sugar management, and digestive health improvement. It is widely sourced from oats, barley, yeast, and mushrooms for use in functional foods, nutraceuticals, and pharmaceutical products. Alpha-glucan is also gaining attention for its applications in food ingredients, cosmetics, and biotechnology. Increasing consumer preference for natural and plant-based health ingredients continues to drive demand across glucan types.

Market Segmentation
Type	Beta-Glucan, Alpha-Glucan, Others
Product	Cereal-based Glucan, Yeast-based Glucan, Mushroom-based Glucan, Seaweed-based Glucan, Others
Technology	Biotechnology, Enzymatic Extraction, Others
Component	Active Ingredient, Additive, Others
Application	Food & Beverages, Pharmaceuticals, Cosmetics & Personal Care, Animal Feed, Nutraceuticals, Functional Foods, Dietary Supplements, Others
Form	Powder, Liquid, Capsules, Tablets, Others
Process	Extraction, Fermentation, Purification, Others
End User	Food Industry, Pharmaceutical Industry, Cosmetic Industry, Animal Nutrition Industry, Others
Functionality	Immune Health, Cholesterol Management, Blood Sugar Management, Digestive Health, Others

The End User segment of the Glucan Market includes the food industry, pharmaceutical industry, cosmetic industry, animal nutrition industry, and others. The food industry accounts for a significant market share due to the increasing incorporation of glucan into functional foods, beverages, and dietary supplements to enhance nutritional value and health benefits. The pharmaceutical industry is expanding its use of glucan in immune-support formulations and therapeutic products, while the cosmetic industry utilizes glucan for skin hydration and anti-aging applications. The animal nutrition industry is also adopting glucan as a natural feed additive to improve immunity and overall livestock health.

Geographical Overview

North America held the largest share of the global Glucan Market in 2025, supported by increasing demand for functional ingredients, growing health awareness, and expanding applications of glucan-based products across nutraceuticals, pharmaceuticals, food & beverages, and animal nutrition sectors. The United States and Canada are major contributors due to strong consumer interest in immune-supporting supplements, well-established dietary supplement industries, and significant investments in health and wellness products. The region benefits from the presence of leading biotechnology companies, advanced research capabilities, and widespread adoption of beta-glucan ingredients in functional foods and preventive healthcare products. Furthermore, rising demand for natural bioactive compounds, increasing focus on immune health, and growing incorporation of glucans into personalized nutrition solutions are strengthening North Americas leadership in the global glucan market.

The Asia Pacific Glucan Market is expected to register the highest growth during the forecast period, driven by rising health consciousness, expanding nutraceutical industries, and increasing adoption of functional foods and dietary supplements. Countries such as China, Japan, India, South Korea, and Australia are witnessing growing demand for glucan-based ingredients due to increasing consumer focus on immunity enhancement, preventive healthcare, and natural wellness products. The region benefits from a large population base, improving healthcare infrastructure, and growing investments in biotechnology and food ingredient innovation. Additionally, rising disposable incomes, increasing awareness of the benefits of beta-glucans, and expanding applications in pharmaceuticals, cosmetics, and animal feed are accelerating market growth, positioning Asia Pacific as the fastest-growing regional market for glucan products.

Key Trends and Drivers

Growing Adoption of Beta-Glucan in Functional Foods and Immune Health Products:

The Glucan Market is witnessing a growing trend toward the incorporation of beta-glucan ingredients in functional foods, dietary supplements, and nutraceutical products due to increasing consumer focus on preventive healthcare and immune support. Beta-glucans derived from sources such as oats, yeast, and mushrooms are gaining popularity for their recognized health benefits, including immune system support, cholesterol management, and improved gut health. Food and beverage manufacturers are increasingly developing fortified products such as cereals, beverages, supplements, and wellness formulations containing glucan ingredients. The rising demand for clean-label, natural, and health-oriented ingredients is encouraging innovation and expanding applications of glucans across the nutrition and healthcare sectors.

Increasing Consumer Demand for Immunity-Boosting and Health-Enhancing Ingredients:

The rising awareness of immune health, functional nutrition, and preventive wellness is a major driver of the Glucan Market. Consumers are increasingly seeking natural bioactive ingredients that provide additional health benefits beyond basic nutrition, increasing demand for glucan-based supplements and fortified food products. The growing prevalence of lifestyle-related health concerns and increasing interest in maintaining cardiovascular and digestive health are further supporting the adoption of beta-glucan ingredients. Additionally, pharmaceutical, nutraceutical, and food companies are investing in research and product development to utilize glucans in immune-support formulations, dietary supplements, and therapeutic applications, contributing to sustained market growth.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS34729

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Application
2.4 Key Market Highlights by Form
2.5 Key Market Highlights by End User
2.6 Key Market Highlights by Functionality
2.7 Key Market Highlights by Process
2.8 Key Market Highlights by Technology
2.9 Key Market Highlights by Component

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Beta-Glucan
- 4.1.2 Alpha-Glucan
- 4.1.3 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Cereal-based Glucan
- 4.2.2 Yeast-based Glucan
- 4.2.3 Mushroom-based Glucan
- 4.2.4 Seaweed-based Glucan
- 4.2.5 Others
4.3 Market Size & Forecast by Application (2020-2035)
- 4.3.1 Food & Beverages
- 4.3.2 Pharmaceuticals
- 4.3.3 Cosmetics & Personal Care
- 4.3.4 Animal Feed
- 4.3.5 Nutraceuticals
- 4.3.6 Functional Foods
- 4.3.7 Dietary Supplements
- 4.3.8 Others
4.4 Market Size & Forecast by Form (2020-2035)
- 4.4.1 Powder
- 4.4.2 Liquid
- 4.4.3 Capsules
- 4.4.4 Tablets
- 4.4.5 Others
4.5 Market Size & Forecast by End User (2020-2035)
- 4.5.1 Food Industry
- 4.5.2 Pharmaceutical Industry
- 4.5.3 Cosmetic Industry
- 4.5.4 Animal Nutrition Industry
- 4.5.5 Others
4.6 Market Size & Forecast by Functionality (2020-2035)
- 4.6.1 Immune Health
- 4.6.2 Cholesterol Management
- 4.6.3 Blood Sugar Management
- 4.6.4 Digestive Health
- 4.6.5 Others
4.7 Market Size & Forecast by Process (2020-2035)
- 4.7.1 Extraction
- 4.7.2 Fermentation
- 4.7.3 Purification
- 4.7.4 Others
4.8 Market Size & Forecast by Technology (2020-2035)
- 4.8.1 Biotechnology
- 4.8.2 Enzymatic Extraction
- 4.8.3 Others
4.9 Market Size & Forecast by Component (2020-2035)
- 4.9.1 Active Ingredient
- 4.9.2 Additive
- 4.9.3 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Application
  - 5.2.1.4 Form
  - 5.2.1.5 End User
  - 5.2.1.6 Functionality
  - 5.2.1.7 Process
  - 5.2.1.8 Technology
  - 5.2.1.9 Component
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Application
  - 5.2.2.4 Form
  - 5.2.2.5 End User
  - 5.2.2.6 Functionality
  - 5.2.2.7 Process
  - 5.2.2.8 Technology
  - 5.2.2.9 Component
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Application
  - 5.2.3.4 Form
  - 5.2.3.5 End User
  - 5.2.3.6 Functionality
  - 5.2.3.7 Process
  - 5.2.3.8 Technology
  - 5.2.3.9 Component
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Application
  - 5.3.1.4 Form
  - 5.3.1.5 End User
  - 5.3.1.6 Functionality
  - 5.3.1.7 Process
  - 5.3.1.8 Technology
  - 5.3.1.9 Component
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Application
  - 5.3.2.4 Form
  - 5.3.2.5 End User
  - 5.3.2.6 Functionality
  - 5.3.2.7 Process
  - 5.3.2.8 Technology
  - 5.3.2.9 Component
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Application
  - 5.3.3.4 Form
  - 5.3.3.5 End User
  - 5.3.3.6 Functionality
  - 5.3.3.7 Process
  - 5.3.3.8 Technology
  - 5.3.3.9 Component
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Application
  - 5.4.1.4 Form
  - 5.4.1.5 End User
  - 5.4.1.6 Functionality
  - 5.4.1.7 Process
  - 5.4.1.8 Technology
  - 5.4.1.9 Component
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Application
  - 5.4.2.4 Form
  - 5.4.2.5 End User
  - 5.4.2.6 Functionality
  - 5.4.2.7 Process
  - 5.4.2.8 Technology
  - 5.4.2.9 Component
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Application
  - 5.4.3.4 Form
  - 5.4.3.5 End User
  - 5.4.3.6 Functionality
  - 5.4.3.7 Process
  - 5.4.3.8 Technology
  - 5.4.3.9 Component
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Application
  - 5.4.4.4 Form
  - 5.4.4.5 End User
  - 5.4.4.6 Functionality
  - 5.4.4.7 Process
  - 5.4.4.8 Technology
  - 5.4.4.9 Component
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Application
  - 5.4.5.4 Form
  - 5.4.5.5 End User
  - 5.4.5.6 Functionality
  - 5.4.5.7 Process
  - 5.4.5.8 Technology
  - 5.4.5.9 Component
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Application
  - 5.4.6.4 Form
  - 5.4.6.5 End User
  - 5.4.6.6 Functionality
  - 5.4.6.7 Process
  - 5.4.6.8 Technology
  - 5.4.6.9 Component
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Application
  - 5.4.7.4 Form
  - 5.4.7.5 End User
  - 5.4.7.6 Functionality
  - 5.4.7.7 Process
  - 5.4.7.8 Technology
  - 5.4.7.9 Component
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Application
  - 5.5.1.4 Form
  - 5.5.1.5 End User
  - 5.5.1.6 Functionality
  - 5.5.1.7 Process
  - 5.5.1.8 Technology
  - 5.5.1.9 Component
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Application
  - 5.5.2.4 Form
  - 5.5.2.5 End User
  - 5.5.2.6 Functionality
  - 5.5.2.7 Process
  - 5.5.2.8 Technology
  - 5.5.2.9 Component
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Application
  - 5.5.3.4 Form
  - 5.5.3.5 End User
  - 5.5.3.6 Functionality
  - 5.5.3.7 Process
  - 5.5.3.8 Technology
  - 5.5.3.9 Component
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Application
  - 5.5.4.4 Form
  - 5.5.4.5 End User
  - 5.5.4.6 Functionality
  - 5.5.4.7 Process
  - 5.5.4.8 Technology
  - 5.5.4.9 Component
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Application
  - 5.5.5.4 Form
  - 5.5.5.5 End User
  - 5.5.5.6 Functionality
  - 5.5.5.7 Process
  - 5.5.5.8 Technology
  - 5.5.5.9 Component
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Application
  - 5.5.6.4 Form
  - 5.5.6.5 End User
  - 5.5.6.6 Functionality
  - 5.5.6.7 Process
  - 5.5.6.8 Technology
  - 5.5.6.9 Component
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Application
  - 5.6.1.4 Form
  - 5.6.1.5 End User
  - 5.6.1.6 Functionality
  - 5.6.1.7 Process
  - 5.6.1.8 Technology
  - 5.6.1.9 Component
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Application
  - 5.6.2.4 Form
  - 5.6.2.5 End User
  - 5.6.2.6 Functionality
  - 5.6.2.7 Process
  - 5.6.2.8 Technology
  - 5.6.2.9 Component
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Application
  - 5.6.3.4 Form
  - 5.6.3.5 End User
  - 5.6.3.6 Functionality
  - 5.6.3.7 Process
  - 5.6.3.8 Technology
  - 5.6.3.9 Component
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Application
  - 5.6.4.4 Form
  - 5.6.4.5 End User
  - 5.6.4.6 Functionality
  - 5.6.4.7 Process
  - 5.6.4.8 Technology
  - 5.6.4.9 Component
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Application
  - 5.6.5.4 Form
  - 5.6.5.5 End User
  - 5.6.5.6 Functionality
  - 5.6.5.7 Process
  - 5.6.5.8 Technology
  - 5.6.5.9 Component

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Cargill
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Tate & Lyle
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Kerry Group
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 DSM
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Ingredion
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Lesaffre
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 ABF Ingredients
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Angel Yeast
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Biorigin
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Lallemand
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Ohly
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Alltech
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Biotec Pharmacon
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Garuda International
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Super Beta Glucan
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 AHD International
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Biothera Pharmaceuticals
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Ceapro
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 NutraQ
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 BetaBioTech
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us